<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_XJTLU-CHINA skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:XJTLU-CHINA</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="container"><NAV class="navbar navbar-default navbar-fixed-top" style="box-shadow: 1px 2px 4px rgba(43,43,43,0.5); margin-bottom: 0px"><DIV class="container-fluid"><DIV class="navbar-header"><BUTTON type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-target="#bs-example-navbar-collapse-1" aria-expanded="false"><SPAN class="sr-only">Toggle navigation</SPAN></BUTTON></DIV><DIV class="collapse navbar-collapse" id="bs-example-navbar-collapse-1"><UL class="nav navbar-nav"><LI style="margin-left: 100px"><A href="https://2018.igem.org/Team:XJTLU-CHINA">Home</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Project </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Exosome_Biogenesis">Exosome Biogenesis</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/RNA_Packaging">RNA Packaging</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Targeting_And_Delivery">Targeting and Delivery</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/RNA_Stabilization">RNA Stabilization</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Demonstrate">Results</A></LI></UL><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Modeling </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Model">Our Model</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Modelling1">Pharmacokinetic model</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Modelling2">mRNA delivery simulation</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Modelling3">Functional exosome production system</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Human Practice</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/HP/Silver">Silver</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/HP/Gold">Gold</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Education">Education</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Survey_And_Policy">Survey and Policy</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Notebook </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Labbook">Lab Book</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Protocols">Protocols</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Parts </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Basic_Part">Basic Parts</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Composite_Part">Composite Parts</A></LI><LI class="dropdown"><A href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" aria-haspopup="true" aria-expanded="false">Team </A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Team">Members</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Attributions">Attribution</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/Safety">Safety</A></LI><LI><A href="https://2018.igem.org/Team:XJTLU-CHINA/InterLab">InterLab</A></LI></DIV></DIV></NAV></DIV><DIV class="row" style="background-color: white"><DIV class="col-sm-10"><H1 style="font-size: 40px; font-family:'Impact'; color: #337ab7; text-align: center">
            A nervous system-targeting exosome device to transport mRNA             </H1><P style="font-size: 18px; margin-top: 20px; margin-bottom: 40px">
           In recent decades, scientists have advanced various drug delivery modalities to overcome the blood-brain barrier (BBB), which excludes most neurotherapeutics from entering the central nervous system (CNS), in order to treat CNS disorders. The emerging brain virotherapy using AAV vectors was reported to be immunogenic and costly in manufacturing. In addition, it is rather perilous that therapeutic viruses have to be administered into the cerebrospinal fluid. Hence, this year, our team aims to engineer HEK293T cells to produce therapeutic exosomes, which are extracellular vesicles naturally capable of traversing the BBB, thereby providing a low-risk platform for CNS mRNA therapy . The engineering steps include: 1. boosting the production of exosomes; 2. facilitating therapeutic RNA to be packaged into exosomes; 3. increasing targeting specificity to neurons with low leakage during the transport of RNA cargo 4. prolonging the expression of therapeutic RNAs in neurons 
        </P></DIV></DIV><DIV class="container-fluid" style="padding-bottom:80px; background-color: rgb(84,146,197); background-position: center; padding-right: 0px; padding-left: 0px"><DIV style="background-color: white; box-shadow: 0px 0px 4px rgba(0,0,0,0.56);"><DIV class="container-fluid" id="partOne" style="padding-left: 80px; padding-right: 80px"><DIV class="container-fluid" style="background-color: white; padding-top:50px; width: 100%; margin-top: 0px;"><DIV class="col-md-7 wow"><H1 style="font-size: 40px; font-family:'Impact'; color: #337ab7;">Exosome biogenesis</H1><P style="font-size: 18px; margin-top: 20px">
                    This year, we decided to use human embryonic kidney cells (HEK293T) to produce engineered exosomes. We genetically modified HEK293T to increase the production of exosomes so that the resulting therapeutic exosomes could reach the CNS with a relatively effective dose after circulating in the blood stream and the BBB.
                </P></DIV></DIV></DIV><DIV class="container-fluid" style="padding-top: 40px;padding-left: 80px; padding-right: 80px" id="partTwo"><DIV class="container-fluid" style="background-color: white; padding-top:50px; width: 100%; margin-top: 0px; border-top: 1px solid #337ab7"><DIV class="col-md-7 wow"><H1 style="font-size: 40px; font-family:'Impact'; color: #337ab7;">RNA Packaging</H1><P style="font-size: 18px; margin-top: 20px">
                   Since exosomes are quite randon in content packaging, we modified exosomes to be capable of packaging our designed therapeutic mRNA in larger amount. To achieve this goal, an RNA-protein interaction strategy was utilized. The L7Ae-C/D box and MS2-3 loop interactions were being utilized in our project.
                </P></DIV></DIV></DIV><DIV class="container-fluid" style="padding-top: 50px;padding-left: 80px; padding-right: 80px" id="partThree"><DIV class="container-fluid" style="background-color: white; padding-top:50px; padding-bottom: 50px; width: 100%; margin-top: 0px; border-top: 1px solid #337ab7"><DIV class="col-md-7 wow"><H1 style="font-size: 40px; font-family:'Impact'; color: #337ab7;">Exosome targeting and delivery</H1><P style="font-size: 18px; margin-top: 20px">
                    Exosome has been known to be a messenger responsible for intracellular communication where the exosomes can be endocytosed non-specifically by other tissues or cells. Therefore, from the perspective of therapy, the efficiency of this exosome-based mRNA therapy is probably not efficient enough. To lower this concern, we enhanced neuron-targeting specificity by using the interaction between RVG (rabies viral glycoprotein), 2 gap junctions proteins--connexin 43 and connexin 36 and neuronal cells in our project design.
                </P></DIV></DIV></DIV><DIV class="container-fluid" style="padding-top: 40px;padding-left: 80px; padding-right: 80px"><DIV class="container-fluid" style="margin-bottom: 50px; background-color: white; padding-top:50px; width: 100%; margin-top: 0px; border-top: 1px solid #337ab7"><DIV class="col-md-7 wow"><H1 style="font-size: 40px; font-family:'Impact'; color: #337ab7;">RNA stabilization</H1><P style="font-size: 18px; margin-top: 20px">
                   In the light of the ubiquity of RNases and the delicacy of RNA, which pose the main impediments to mRNA therapy, we utilized the 3' UTR fragment (non-immunogenic)of Venezuelan equine encephalitis virus (VEEV) to generate therapeutic mRNA to evade the classical deadenylation degradation pathway.            </P></DIV></DIV></DIV></DIV></DIV><DIV style="border-top: 1px solid rgba(0,0,0,0.15); background-color: white; padding-bottom: 50px; margin-bottom: 0px; padding-top: 50px"><DIV class="row"><DIV class="col-xs-5"><H1 style="font-size: 40px; font-family:'Impact'; color: #337ab7;">Video of project concept</H1><P style="font-size: 18px">
                Click the video aside to obtain an immediate understanding of our project this year.
            </P></DIV></DIV></DIV><DIV style="border-top: 1px solid rgba(0,0,0,0.15); background-color: white; padding-bottom: 50px"><DIV style="text-align: center; padding-top: 40px; "><H1 style="margin: 0px auto; font-family:'Impact'; color: #337ab7;">Collaborators and Supporters</H1></DIV></DIV><DIV class="container-fluid" style="border-top: 1px solid rgba(0,0,0,0.15); height: 240px; padding-top: 30px; background-color: rgb(84,146,197);"><DIV class="row" style="padding: 0px 50px"><DIV class="col-md-4"><DIV><P style="font-size: 26px;  color: white;">Location</P></DIV><DIV><P style="line-height: 15px; font-size: 16px; color: white;">Rm 363, Science Building</P><P style="line-height: 15px; font-size: 16px; color: white;">Xi'an Jiaotong-Liverpool University</P><P style="line-height: 15px; font-size: 16px; color: white;">111 Ren'ai Road, Suzhou, China</P><P style="line-height: 16px; font-size: 16px; color: white;">215123</P></DIV></DIV><DIV class="col-md-4"><DIV><P style="font-size: 26px;  color: white;">Social</P></DIV><DIV><P style="line-height: 15px; font-size: 16px; color: white;">FB</P></DIV></DIV><DIV class="col-md-3"><DIV><P style="font-size: 26px;  color: white;">Get in touch</P></DIV><DIV><P style="line-height: 15px; font-size: 16px; color: white;">igem@xjtlu.edu.cn</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>